021-51111890
购物车（）
sales@molnova.cn
RS 67333 hydrochloride
CAS No. 168986-60-5
RS 67333 hydrochloride ( RS 67333 HCl | RS 67333 (hydrochloride) )
产品货号. M27698 CAS No. 168986-60-5
有效且高选择性的 5-HT4 部分激动剂。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥583 | 有现货 |
|
| 10MG | ￥988 | 有现货 |
|
| 25MG | ￥2333 | 有现货 |
|
| 50MG | ￥3661 | 有现货 |
|
| 100MG | ￥5387 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称RS 67333 hydrochloride
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述有效且高选择性的 5-HT4 部分激动剂。
-
产品描述potent and highly selective 5-HT4 partial agonist.(In Vitro):RS 67333 hydrochloride exhibits affinities for the sigma 1 (pKi = 8.9) and sigma 2 (pKi = 8.0) binding sites. At the 5-HT4 receptor mediating relaxation of the carbachol-precontracted oesophagus, RS 67333 hydrochloride acts as a potent (pEC50 of 8.4), partial agonists (intrinsic activities, with respect to 5-HT is 0.5) with respect to 5-HT .
-
体外实验RS 67333 hydrochloride does exhibit affinities for the sigma 1 (pKi = 8.9) and sigma 2 (pKi = 8.0) binding sites. At the 5-HT4 receptor mediating relaxation of the carbachol-precontracted oesophagus, RS 67333 hydrochloride acts as a potent (pEC50 of 8.4), partial agonists (intrinsic activities, with respect to 5-HT is 0.5) with respect to 5-HT.
-
体内实验——
-
同义词RS 67333 HCl | RS 67333 (hydrochloride)
-
通路Others
-
靶点Other Targets
-
受体c-Fgr|Lyn|Hck|Apoptosis
-
研究领域——
-
适应症——
化学信息
-
CAS Number168986-60-5
-
分子量389.36
-
分子式C19H30Cl2N2O2
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 50 mg/mL (128.42 mM)
-
SMILESCl.CCCCN1CCC(CCC(=O)c2cc(Cl)c(N)cc2OC)CC1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Weir MC, et al. Selective Inhibition of the Myeloid Src-Family Kinase Fgr Potently Suppresses AML Cell Growth in Vitro and in Vivo. ACS Chem Biol. 2018 Jun 15;13(6):1551-1559.
产品手册
关联产品
-
Gp100 619-627
This is a HLA-A*0201 restricted epitope used in melanoma studies.
-
NH2-PEG-FA
Procyanidin B2 3,3-di-O-gallate
-
Sitostenone
谷甾酮具有抗氧化活性。 Stigmasta-4-en-3-one(Sitostenone)可用于治疗雄激素依赖性疾病，特别是用于治疗良性前列腺增生。
